Industry Program

Scheduled within the (Vietnam) GMT +7 timezone and across a week to ensure that you can attend as many sessions as you want. 

The first industry session during the featured program starts on Saturday 24th October at your local time below:

  • Japan (JST) 13:30
  • China (CST) 12:30
  • India (IST) 10:00
  • Bangladesh (BST) 10:30
  • Singapore (SGT) 12:30
  • Malaysia (MYT) 12:30
  • Australia (AEDT) 15:30

The below clock also shows you the current time compared to the advertised APLAR program (GMT+7)

World Clock

Friday 23 October 2020
1400-1700Pre-Congress workshop

CH1
Biomechanics & Movement Workshop with BJC Health


Speakers:

Errol Lim
Managing Director of BJC Health

Dr Irwin Lim
Consultant Rheumatologist

Sarah Comensoli
Exercise Physiologist & Manager of Allied Health services

Dr Herman Lau
Rheumatologist

Robyn Yin
Head Exercise Physiologist

Belinda Price
Physiotherapist

Blanche Leung
Physiotherapist

Heidi Kim
Physiotherapist

Brought to you by


Saturday 24 October
1130 – 1245CH2: Morning symposium 1

“Beyond remission” based on patients’ subjective experiences for improved RA control


Chairpersons:

Professor Masayoshi Harigai
Professor and Chairperson of Department of rheumatology/Tokyo Women’s Medical University

Speakers:

Associate Professor Yuko Kaneko
Associate Professor, Division of Rheumatology and Department of Internal Medicine/Keio University School of Medicine
CH3: Morning symposium 2

Solving the patient puzzle: A pragmatic approach to SpA management


Speakers:

Dr Mitsumasa Kishimoto
Associate Professor, Department of Nephrology and Rheumatology/Kyorin University School of Medicine

Dr Philip Robinson
Associate Professor/Brisbane Rheumatology
CH4: Morning symposium 3

New Treatment Paradigm in RA: Focusing on A Novel JAK inhibitor


Chairpersons/Speakers:

Professor Tatsuya Atsumi
Professor of Medicine in the Faculty of Medicine/Hokkaido University

Professor Yoshiya Tanaka
Professor and Chairman of the First Department of Internal Medicine/School of Medicine, University of Occupational and Environmental Health

Professor Tsutomu Takeuchi
Professor of Rheumatology, Department of Internal Medicine/Keio University School of Medicine

Morning symposium 4
Brought to you by Brought to you by Brought to you by
1315 – 1445CH1: Lunch symposium 1

Prospects for JAK inhibitors in the treatment of rheumatoid arthritis

Speakers:


Dr Kei Ikeda
Senior Lecturer, Department of Allergy and Clinical Immunology/Chiba University Hospital

Dr Akio Morinobu
Department of Rheumatology, Kyoto University Graduate School of Medicine

Brought to you by

CH2: Lunch symposium 2

Basic and Clinical of Rheumatology

Chairpersons:


Professor Masataka Kuwana
Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence/Nippon Medical School

Speakers:

Professor Yoshiya Tanaka
Professor and Chairman of the First Department of Internal Medicine/School of Medicine, University of Occupational and Environmental Health

Brought to you by

1740 – 1840CH1: Evening symposium 1

Management of RA in 2020: is remission achievable and where do JAKs fit?


Speakers:

Professor Gerd-Rüdiger Burmester
Medicine Director of the department of Rheumatology

Associate Professor Peter Nash
Department of Medicine/University of Queensland, Brisbane, AUSTRALIA
CH2: Evening symposium 2

Treat-to-target in SLE: addressing short- and long-term treatment goals


Chariperson:

Professor Yoshiya Tanaka
Professor and Chairman of the First Department of Internal Medicine/School of Medicine, University of Occupational and Environmental Health

Speakers:

Professor Yoshiya Tanaka
Professor and Chairman of the First Department of Internal Medicine/School of Medicine, University of Occupational and Environmental Health

Professor Ian Bruce
National Institute of Health Research (NIHR) Senior Investigator and Professor of Rheumatology/University of Manchester

Professor Nancy Agmon-Levin
Consultant/Tel Aviv and Chaim Sheba Medical Center
CH3: Evening symposium 3

ILD in Focus: Time to prioritize the lung in CTDs


Chairperson:

Professor Masataka Kuwana
Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence/Nippon Medical School

Speakers:

Professor Masataka Kuwana
Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence/Nippon Medical School

Professor Yannick Allanore
Professor of Rheumatology/University of Paris

Professor Marco Matucci-Cerinic
Professor of Rheumatology and Medicine at the Department of Experimental and Clinical Medicine/Careggi University Hospital of Florence
CH4: Evening symposium 4

Perspectives around the accumulated evidence for IL-6 in autoimmune disease

Chairpersons/Speakers:


Dr Kunihiro Yamaoka
Division of Rheumatology, Kitasato University Hospital, Japan

Dr Shinsuke Yasuda
Tokyo Medical and Dental University, Department of Rheumatology, Japan
Brought to you byBrought to you byBrought to you byBrought to you by

Sunday 25 October
1130 – 1245CH2: Morning symposium 5

Treatment of Rheumatoid Arthritis: Past and Future

Speakers:


Masaru Kato
Department of Rheumatology, Endocrinology and Nephrology, Graduate School of Medicine, Hokkaido University
CH3: Morning symposium 6

To continue, taper or discontinue biologics – Implications on RA treatment outcomes


Chairpersons:

Professor Yoshiya Tanaka
University of Occupational and Environmental Health, Kitakyushu, JAPAN

Speakers:

Associate Professor Peter Nash
Department of Medicine / University of Queensland, Brisbane, AUSTRALIA

Associate Professor Khoa Dinh Nguyen
Cho Ray Hospital, Ho Chi Minh City, VIETNAM

Professor Wen-Chan Tsai
Kaohsiung Medical University Hospital, Kaohsiung, TAIWAN
CH4: Morning symposium 7

Denosumab, anti-RANKL antibody, for the treatment of joint destruction in RA. − From DRIVE & DESIRABLE studies


Chairpersons:

Professor Tatsuya Atsumi
Professor of Medicine in the Faculty of Medicine / Hokkaido University

Speakers:

Professor Tsutomu Takeuchi
Professor of Rheumatology, Department of Internal Medicine/Keio University School of Medicine
Brought to you by Brought to you by Brought to you by
1315 – 1445CH1: Lunch symposium 3

New insights for clinical practice in Spondyloarthritis, SpA


Chairpersons:

Associate Professor Yuko Kaneko
Associate Professor, Division of Rheumatology and Department of Internal Medicine/Keio University School of Medicine

Professor Naoto Tamura
Professor and Chairman, Department of Internal Medicine and Rheumatology/Juntendo University School of Medicine

Speakers:

Dr Kei Ikeda
Senior Lecturer, Department of Allergy and Clinical Immunology/Chiba University Hospital

Dr Kenta Misaki
Chief Director, Department of Rheumatology/Kita-Harima Medical Center

Professor Yuho Kadono
Chief Administrator, Orthopedic Surgery/Saitama Medical University

CH2: Lunch symposium 4

Innovative therapeutic alternatives for RA, PsA, AS and nr-axSpA: Individualising the treatment approach


Chairperson:

Dr Kunihiro Yamaoka
Division of Rheumatology, Kitasato University Hospital, Japan

Speakers:

Dr Kunihiro Yamaoka
Division of Rheumatology, Kitasato University Hospital, Japan

Professor Lars Erik Kristensen
Parker Institute / University Copenhagen

Professor Andrew Ostör
Cabrini Medical Centre / Emeritus Research

Brought to you by

Brought to you by
1740 – 1840CH1: Evening symposium 5

Addressing Unmet Needs in RA and PsA: The Right Drug for the Right Patient

Chairpersons:


Professor Tsutomu Takeuchi
Professor of Rheumatology,
Department of Internal Medicine/Keio University School of Medicine

Speakers:

Professor Yoshiya Tanaka
Professor and Chairman of the First Department of Internal Medicine / School of Medicine,
University of Occupational and Environmental Health

Professor Filip Van den Bosch
Professor of Rheumatology and Head-of-Clinic,
Department of Rheumatology
/ University Hospital of Ghent University

Professor Tsutomu Takeuchi
Professor of Rheumatology,
Department of Internal Medicine/Keio University School of Medicine
CH2: Evening symposium 6

Evolution of interleukin-6 inhibiting therapies for rheumatoid arthritis

Chairpersons:


Dr Yutaka Kawahito M.D., Ph.D.
Head of the Department of Inflammation and Immunology/Kyoto Prefectural University of Medicine

Speakers:

Dr Motomu Hashimoto
Department of Advanced Medicine for Rheumatic Diseases, Kyoto University.


Brought to you by
Brought to you by

Wednesday 28 October 2020
1630-1730Evening symposium 3

ILD in Focus: Time to prioritize the lung in CTDs


Chairperson:

Professor Masataka Kuwana
Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence / Nippon Medical School

Speakers:

Professor Marco Matucci-Cerinic
Professor of Rheumatology and Medicine at the Department of Experimental and Clinical Medicine/Careggi University Hospital of Florence

Professor Yannick Allanore
Professor of Rheumatology / University of Paris

Professor Masataka Kuwana
Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence / Nippon Medical School

Brought to you by